Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

Published

Journal Article

A national survey of Bacteroides fragilis group was continued in 1989 for the ninth consecutive year. Seven hundred thirty-nine isolates of B fragilis group from eight centers were tested for susceptibility to 14 antimicrobials. Sulbactam and clavulanic acid, beta-lactamase inhibitors, were tested at a constant concentration of 8 micrograms/ml and 2 micrograms/ml, respectively. Sulbactam was also tested in a fixed ratio of 1:2. Imipenem, ampicillin+sulbactam, and ticarcillin+clavulanic acid had resistance of less than 1% at breakpoints of 8 micrograms/ml, 16 micrograms/ml, and 64 micrograms/ml, respectively. At 32 micrograms/ml, resistance to cefoxitin, cefotetan, ceftizoxime, and ceftriaxone were 4%, 25%, 26%, and 46%, respectively. Clindamycin resistance was 10% at a breakpoint of 4 micrograms/ml. No isolates were resistant to chloramphenicol or metronidazole. Resistance for five B fragilis species to cefoxitin, ceftizoxime, and cefotetan varied greatly among both species and participating institutions. The addition of a beta-lactamase inhibitor increased the potency of the beta-lactam drugs tested as combinations. This finding suggests that beta-lactamase production is the major resistance factor in members of the B fragilis group.

Full Text

Duke Authors

Cited Authors

  • Cuchural, GJ; Snydman, DR; McDermott, L; Iannini, PB; Hill, GB; Cleary, TJ; O'Keefe, JP; Pierson, CL; Rihs, JD; Finegold, SM

Published Date

  • January 1, 1992

Published In

Volume / Issue

  • 14 / 1

Start / End Page

  • 122 - 136

PubMed ID

  • 1576621

Pubmed Central ID

  • 1576621

International Standard Serial Number (ISSN)

  • 0149-2918

Language

  • eng

Conference Location

  • United States